Skip to main content

The Biology and Natural History of Prostate Cancer: A Short Introduction

  • Chapter
  • First Online:
Prostate Cancer Prevention

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 202))

Abstract

This chapter aims to serve as a quick glance outlining an overall picture of mainstream thoughts, and to serve as a point of departure for more thorough discussions. The introduction of PSA testing has immensely complicated research in prostate cancer epidemiology and biology and added new clinical and biological domains. As for many cancers, age and ethnic origin are the strongest known risk factors. While migrant studies imply that environment and/or personal life style is important, epidemiological studies have failed to establish any strong leads. Despite the known androgen dependence of prostate cancer, there is little to support that circulating levels of androgens, estrogens or 5-alpha-reductase are associated with risk of developing the disease. However, a consistent finding is a positive association with levels of Insulin-like Growth Factor-1 (IGF-1). Prostate cancer is one of the cancers most strongly related to inherited susceptibility, even when taking into account that family history of prostate cancer triggers PSA testing among relatives. A number of somatic genetic alterations (amplifications, deletions, point mutations, translocations) are associated with prostate cancer risk. Findings for alterations in FASN, HPN, AMACR and MYC have been fairly consistent. Recent research shows that the notion of “hormone-independent prostate cancer” has to be revised: most prostate cancers remain dependent on androgen receptor signalling also after progression despite traditional androgen deprivation therapy. Traditional markers of stage and type of disease still play a major role for prognostication and treatment decisions. Prostate cancer is one of the few cancers where patients have been recommended watchful waiting or active surveillance. This provides opportunities for studies of natural history of the disease. The understanding of prostate cancer aetiology and natural history has progressed slowly. However, the current situation is positively challenging and opens up possibilities for fruitful research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alexander DD, Mink PJ, Cushing CA, Sceurman B (2010) A review and meta-analysis of prospective studies of red and processed meat intake and prostate cancer. Nutr J 9:50

    Article  PubMed Central  PubMed  Google Scholar 

  • Alva A, Hussain M (2013) The changing natural history of metastatic prostate cancer. Cancer J 19(1):19–24

    Google Scholar 

  • Attard G, Clark J, Ambroisine L, Fisher G, Kovacs G, Flohr P et al (2008) Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene 27(3):253–63

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Baca SC, Garraway LA (2012) The genomic landscape of prostate cancer. Front Endocrinol (Lausanne) 3:69

    Google Scholar 

  • Bambury RM, Gallagher DJ. Prostate cancer: germline prediction for a commonly variable malignancy. BJU Int. 2012 Dec;110(11 Pt C):E809-18

    Google Scholar 

  • Barbieri CE, Bangma CH, Bjartell A, Catto JW, Culig Z, Gronberg H et al. (2013). The Mutational Landscape of Prostate Cancer. Eur Urol 64(4):567–76

    Google Scholar 

  • Benedettini E, Nguyen P, Loda M (2008) The pathogenesis of prostate cancer: from molecular to metabolic alterations. Diagn Histopathol (Oxf) 14(5):195–201

    Article  Google Scholar 

  • Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C et al (2011) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 364(18):1708–17

    Article  CAS  PubMed  Google Scholar 

  • Buschemeyer WC 3rd, Freedland SJ (2007) Obesity and prostate cancer: epidemiology and clinical implications. Eur Urol 52(2):331–43

    Article  PubMed  Google Scholar 

  • Choudhury AD, Eeles R, Freedland SJ, Isaacs WB, Pomerantz MM, Schalken JA et al (2012) The role of genetic markers in the management of prostate cancer. Eur Urol 62(4):577–87

    Article  CAS  PubMed  Google Scholar 

  • Davies NJ, Batehup L, Thomas R (2011) The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer 8(105 Suppl 1):S52–73

    Article  Google Scholar 

  • Gilbert R, Martin RM, Beynon R, Harris R, Savovic J, Zuccolo L et al (2011) Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis. Cancer Causes Control 22(3):319–40

    Article  PubMed  Google Scholar 

  • Green SM, Mostaghel EA, Nelson PS (2012) Androgen action and metabolism in prostate cancer. Mol Cell Endocrinol 360(1–2):3–13

    Article  CAS  PubMed  Google Scholar 

  • Gurel B, Iwata T, Koh CM, Yegnasubramanian S, Nelson WG, De Marzo AM (2008) Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets. Adv Anat Pathol 15(6):319–31

    Google Scholar 

  • Jeronimo C, Bastian PJ, Bjartell A, Carbone GM, Catto JW, Clark SJ et al (2011) Epigenetics in prostate cancer: biologic and clinical relevance. Eur Urol 60(4):753–66

    Article  CAS  PubMed  Google Scholar 

  • Klotz L (2012) Cancer overdiagnosis and overtreatment. Curr Opin Urol 22(3):203–9

    Article  PubMed  Google Scholar 

  • Nacusi LP, Tindall DJ (2011) Targeting 5alpha-reductase for prostate cancer prevention and treatment. Nat Rev Urol 8(7):378–84

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Perry AS (2013) Prostate cancer epigenomics. J Urol 189(1):10–1

    Article  PubMed  Google Scholar 

  • Popiolek M, Rider JR, Andren O, Andersson SO, Holmberg L, Adami HO et al (2013) Natural history of early, localized prostate cancer: a final report from three decades of follow-up. Eur Urol 63(3):428–35

    Article  PubMed  Google Scholar 

  • Rajarubendra N, Lawrentschuk N, Bolton DM, Klotz L, Davis ID (2011) Prostate cancer immunology—an update for Urologists. BJU Int 107(7):1046–51

    Article  CAS  PubMed  Google Scholar 

  • Reid AH, Attard G, Ambroisine L, Fisher G, Kovacs G, Brewer D et al (2010) Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer 102(4):678–84

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Simard J, Dumont M, Soucy P, Labrie F (2002) Perspective: prostate cancer susceptibility genes. Endocrinology 143(6):2029–40

    Article  CAS  PubMed  Google Scholar 

  • Szymanski KM, Wheeler DC, Mucci LA (2010) Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr 92(5):1223–33

    Article  CAS  PubMed  Google Scholar 

  • Tufts Evidence-based Practice Center (2011) An evidence review of active surveillance in men with localized prostate cancer. Agency for Healthcare Research and Quality. Boston

    Google Scholar 

  • Venkateswaran V, Klotz LH (2010) Diet and prostate cancer: mechanisms of action and implications for chemoprevention. Nat Rev Urol 7(8):442–53

    Article  CAS  PubMed  Google Scholar 

  • Wilson KM, Giovannucci EL, Mucci LA (2012) Lifestyle and dietary factors in the prevention of lethal prostate cancer. Asian J Androl 14(3):365–74

    Article  CAS  PubMed  Google Scholar 

  • Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S et al (2012) Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367(3):203–13

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Yu C, Yao Z, Jiang Y, Keller ET (2012) Prostate cancer stem cell biology. (Minerva urologica e nefrologica) Ital J Urol Nephrol 64(1):19–33

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lars Holmberg .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Holmberg, L., Van Hemelrijck, M. (2014). The Biology and Natural History of Prostate Cancer: A Short Introduction. In: Cuzick, J., Thorat, M. (eds) Prostate Cancer Prevention. Recent Results in Cancer Research, vol 202. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45195-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-45195-9_1

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-45194-2

  • Online ISBN: 978-3-642-45195-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics